9 Amendments of Jude KIRTON-DARLING related to 2016/2057(INI)
Amendment 43 #
Draft opinion
Paragraph 5
Paragraph 5
5. Highlights the negative impact of Member States’' austerity policies and stresses that budgetary cuts should not prevent any EU citizenparticularly as they hit the poorest, sickest and least healthy regions of the EU hardest, stresses that budgetary cuts invariably have negative health impacts on citizens therefore action is needed to ensure that no EU citizen is prevented from being able to access medicines;
Amendment 50 #
Draft opinion
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Notes that austerity is undermining citizens right to health in Europe, notably by Member States contravening the principle of non- regression with regards to their own health care policies and funding of health care systems;
Amendment 68 #
Draft opinion
Paragraph 8
Paragraph 8
8. Calls on the Member States to support research and development (R&D) that focuses on the medical needs of all citizens and to guarantee affordable and non-discriminatorypricing for citizens, guarantees non-exclusive licensing where R&D is largely publicly funded, and that access to medical advances in the European Union is non- discriminatory;
Amendment 70 #
Draft opinion
Paragraph 8 – subparagraph 1 (new)
Paragraph 8 – subparagraph 1 (new)
Underlines the importance of information-sharing and cooperation between Member States on pricing, reimbursement and procurement policies, as well as cooperation between stakeholders in order to facilitate better balancing of the value of innovation with equitable, affordable patient access.
Amendment 72 #
Draft opinion
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Calls for a new Transparency Directive following the withdrawal of Directive 89/105/EEC, which aims to ensure the measures established by EU countries to control the pricing and reimbursement of medicinal products are transparent; and ensures that the cost of production of medicines is transparent;
Amendment 74 #
Draft opinion
Paragraph 8 b (new)
Paragraph 8 b (new)
8b. Calls on the European Commission to promote measures to stimulate the uptake of generic medicines, which can effectively lower costs and reduce overall expenditure on medicines;
Amendment 75 #
Draft opinion
Paragraph 8 c (new)
Paragraph 8 c (new)
8c. Calls on member states to investigate the benefits of potential cooperation of lower costs of medicines for citizens via joint purchasing mechanisms;
Amendment 76 #
Draft opinion
Paragraph 8 d (new)
Paragraph 8 d (new)
8d. Calls on the European Commission to develop a European framework, to provide reliable, timely and transparent, comparable and transferable information on the relative efficacy of health technologies to support Member States' decisions;
Amendment 79 #
Draft opinion
Paragraph 9
Paragraph 9
9. Underlines that free trade agreements such as TTIP and TiSA may seriously damage Member States’ healthcare systems, paving the way for wider liberalisation and privatisation in vital sectors and further undermining the principle of universal access to healthcare; therefore reiterates the European Parliament's call for a full carve out for services of general economic interest including healthcare; from their scope of application;